Abstract: A device for the controlled delivery of a beneficial agent is disclosed. The device comprises (a) a formulation layer and (b) a layer comprising means for pushing the formualtion layer from said device. The formulation layer comprises the beneficial agent avermectin or ivermectin.
Type:
Grant
Filed:
August 11, 1986
Date of Patent:
January 5, 1988
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Richard Cortese, Felix A. Landrau
Abstract: A dosage form is disclosed for delivering a beneficial agent. The dosage form comprises a wall that surrounds and defines an internal space, a composition comprising a beneficial agent, means in the space for aiding in delivering the compositions from the dosage form and, at least one passageway in the wall for delivering the composition from the dosage form.
Type:
Grant
Filed:
June 23, 1986
Date of Patent:
January 5, 1988
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Richard Cortese, Felix A. Landrau
Abstract: A laminated arrangement useful for manufacturing a deliver device for delivering a beneficial agent formulation is disclosed. The laminated arrangement comprise first lamina means comprising a beneficial agent formulation in laminar arrangement with a second lamina means exhibiting a lower passage to the beneficial agent then the first lamina means.
Type:
Grant
Filed:
August 11, 1986
Date of Patent:
January 5, 1988
Assignee:
Alza Corporation
Inventors:
James B. Eckenhoff, Richard Cortese, Felix A. Landrau
Abstract: A dispenser is disclosed for delivering a beneficial agent to an environment of use. The dispenser comprises a semipermeable wall surrounding a compartment containing a heat responsive composition, and an expandable composition. A passageway in the wall connects the compartment with the exterior of the dispenser.
Type:
Grant
Filed:
February 12, 1986
Date of Patent:
December 29, 1987
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Felix Theeuwes, Joseph C. Deters
Abstract: An osmotic device is disclosed for delivering a drug to the colon. The device comprises a laminated wall surrounding a compartment containing a drug with a passageway through the wall for dispensing the drug from the device. The laminated wall comprises three laminae, an inner semipermeable lamina, a middle lamina containing a salt of a fatty acid and an outer enteric lamina.
Abstract: A method is disclosed for treating an ischemic condition. The method comprises coadministering topically and internally a vasodilator to a patient having the condition for treating said condition.
Abstract: A dispensing device is disclosed for delivering a beneficial agent. The device comprises (1) a housing defining an internal space, (2) an expandable composition comprising a dense member in the space, (3) a composition comprising a beneficial agent and a non-toxic heat responsive carrier in the space, and (4) a passageway in the housing for delivering the beneficial agent from the dispensing device.
Abstract: A medical device and method for the pulsatile administration of a drug through intact skin at a first steady state flux during a first delivery period and a second steady state flux during a second delivery period, said first flux being substantially higher than said second flux; said first and second delivery periods comprising a substantial portion of a predetermined administration period. The device comprises a reservoir of said drug containing an amount of drug sufficient to administer drug at said first and second steady state fluxes during administration period; a reservoir of a skin permeation enhancer for said drug; said reservoir containing an amount of said permeation enhancer sufficient to permit administration of said drug at said first flux only through said first delivery period; and means for maintaining said device on the skin in drug and permeation enhancer transferring relationship thereto a preferred embodiment delivering nitroglycerin and employing ethanol as a permeation enhancer.
Abstract: A drug delivery device is disclosed for delivering a drug by the oral route to the colon. The device comprises a laminated wall formed of three laminae surrounding a compartment contacting a drug with a passageway through the wall for dispensing the drug.
Abstract: A dispensing device is disclosed for delivering a beneficial agent. The device comprises (1) a housing defining an internal space, (2) a heat responsive composition containing a beneficial agent in the space, (3) an expandable member in the space, and (4) at least one passageway in the housing for delivering the beneficial agent from the dispensing device.
Type:
Grant
Filed:
August 7, 1985
Date of Patent:
September 8, 1987
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Richard Cortese, Felix A. Landrau
Abstract: An intravenous delivery system is disclosed for formulating an intravenously administrable solution in the delivery system. The delivery system comprises means for transferring a fluid and for mixing the fluid with a drug in the delivery system.
Abstract: A dispenser is disclosed for delivering a beneficial agent to an environment of use. The dispenser comprises a semipermeble wall surrounding a compartment containing a heat responsive composition, and an expandable composition. A passageway in the wall connects the compartment with the exterior of the dispenser.
Type:
Grant
Filed:
February 14, 1986
Date of Patent:
September 8, 1987
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Felix Theeuwes, Joseph C. Deters
Abstract: A dispenser is disclosed for delivering a beneficial agent. The dispenser comprises (1) a housing defining an internal space, (2) a heat-responsive composition containing a beneficial agent in the space, (3) an osmotically effective solute in the space, and (4) at least one passageway in the housing for delivering the beneficial agent from the dispenser.
Type:
Grant
Filed:
August 8, 1985
Date of Patent:
August 4, 1987
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Richard Cortese, Felix A. Landrau
Abstract: A high flux transdermal nitroglycerin therapeutic system is disclosed which is capable of delivering nitroglycerin through intact human skin at rates of 40 .mu.g/cm.sup.2 hr and preferably in the range of 50-150 .mu.g/cm.sup.2 hr. Ethanol delivered at a rate of from 250-500 .mu.g/cm.sup.2 hr is employed as a permeation enhancer for the nitroglycerin and a rate controlling membrane formed from ethylene vinyl acetate having a vinyl acetate content greater than 11% and preferably between 12-18% provides the appropriate rate control for both the drug and the permeation enhancer. This system is suitable for use in treatment of angina pectoris and congestive heart failure.
Abstract: A delivery system is disclosed comprising a wall surrounding a lumen containing a plurality of dosage delivery devices. The wall is formed of an environment sensitive material that releases the dosage forms into the environment. The dosage forms comprise a semipermeable wall surrounding a compartment containing drug. A passageway through the semipermeable wall releases drug from the dosage form to the environment.
Abstract: A dispenser is disclosed for delivering a beneficial agent to an environment of use. The dispenser comprises a semipermeable wall surrounding a compartment containing a heat responsive composition, and an expandable composition. A passageway in the wall connects the compartment with the exterior of the dispenser.
Type:
Grant
Filed:
February 13, 1986
Date of Patent:
July 7, 1987
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Felix Theeuwes, Joseph C. Deters
Abstract: A dispensing system is disclosed for delivering a beneficial agent. The dispensing system comprises (1) a housing defining an internal space, (2) a gas-generating composition in the space, (3) a dense member in the space, (4) a composition comprising a beneficial agent and a non-toxic heat responsive carrier in the space, and (5) a passageway in the housing for delivering the beneficial agent for the dispensing system.
Abstract: An osmotic device is disclosed for delivering a beneficial agent. The device comprises a wall surrounding a compartment containing drug, a passageway in the wall connecting the exterior of the device with the compartment, and drug in the wall. The device delivers the drug from the compartment and the wall.
Type:
Grant
Filed:
January 8, 1986
Date of Patent:
June 16, 1987
Assignee:
Alza Corporation
Inventors:
George V. Guittard, Joseph C. Deters, Felix Theeuwes, Richard Cortese
Abstract: A parenteral delivery system is disclosed for administering a beneficial agent to a recipient. The system comprises (a) a primary container of a medical fluid; (b) a primary drip chamber in fluid communication with the primary container; (c) a primary formulation chamber in fluid communication with the primary drip chamber and housing an agent dispensing device or a beneficial agent; (d) a secondary container of a medical fluid; (e) a secondary drip chamber in fluid communication with the secondary container; (f) a secondary formulation chamber in fluid communication with the secondary drip chamber and housing an agent dispensing device or a beneficial agent; and (g) a common tubing in communication with the primary formulation chamber and the secondary formulation chamber for communicating the system with the recipient.
Abstract: A dispenser is disclosed for delivering a beneficial agent to an environment of use. The dispenser comprises a semipermeable wall surrounding a compartment containing a heat responsive composition, and an expandable composition. A passageway in the wall connects the compartment with the exterior of the dispenser.
Type:
Grant
Filed:
February 14, 1986
Date of Patent:
May 5, 1987
Assignee:
ALZA Corporation
Inventors:
James B. Eckenhoff, Felix Theeuwes, Joseph C. Deters